<?xml version="1.0" encoding="UTF-8"?>
<p id="Par86">At the end of re-induction therapy, patients will be assessed for response. Patients achieving at least SD and fulfilling the eligibility criteria (Table 
 <xref rid="Tab2" ref-type="table">2</xref>) for continuation on trial will proceed to first randomisation (R1).
</p>
